Bing Zhou

28PUBLICATIONS
19CO-AUTHORS
Pharmaceutical delivery technologiesHaematological tumoursGene and molecular therapyCharacterisation of biological macromoleculesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Oct 23, 2026
Hsc70-Mediated Targeting Chimeras for Targeted Protein Degradation via Chaperone-Mediated Autophagy.

|Mar 16, 2026
Discovery of Novel MLKL PROTAC Degraders for the Treatment of Hepatocellular Carcinoma via Promoting Parthanatos.

Chao Chen, Kaiyuan Liu, Xinlei Wang

|Aug 05, 2025
Discovery of Highly Potent, Selective, and Liver-Targeted THR-β Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis.

Ju Liang, Yipei Gu, Liuyu Hu

|Aug 09, 2024
Discovery of PRMT3 Degrader for the Treatment of Acute Leukemia.

Wanyi Zou, Mengna Li, Shili Wan

|Jul 23, 2024
Discovery of Potent and Selective G9a Degraders for the Treatment of Pancreatic Cancer.

Yunkai Shi, Qianqian Shen, Ruikai Long

|Jul 19, 2024
Discovery of a Highly Potent, Selective and Efficacious USP7 Degrader for the Treatment of Acute Lymphoblastic Leukemia.

Miaomiao Xu, Jingfeng Fu, Yuan Pei

Pageof 5

Frequent Collaborators

5 joint publications

Shaomeng Wang

4 joint publications

Cheng Luo

2 joint publications

Hu Zhou

1 joint publications

Chao-Yie Yang